2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

Cites (623)

Items 201–400 of 623

1. Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial
   Nissen, Steven E., Stroes, Erik, Dent-Acosta, Ricardo E., Rosenson, Robert S., Lehman, Sam J., Sattar, Naveed, Preiss, David, Bruckert, Eric, Ceška, Richard, Lepor, Norman et al. · 2016 · JAMA
2. Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients
   Keene, D., Price, C., Shun-Shin, M. J., Francis, D. P. · 2014 · BMJ
3. Impact of Lipids on Cardiovascular Health
   Ference, Brian A., Graham, Ian, Tokgozoglu, Lale, Catapano, Alberico L. · 2018 · Journal of the American College of Cardiology
4. Cholesterol-Lowering Therapy in Women and Elderly Patients With Myocardial Infarction or Angina Pectoris: Findings From the Scandinavian Simvastatin Survival Study (4S)
   Miettinen, Tatu A., Pyörälä, Kalevi, Olsson, Anders G., Musliner, Thomas A., Cook, Thomas J., Faergeman, Ole, Berg, Kåre, Pedersen, Terje, Kjekshus, John, Group, for the Scandinavian Simvastatin Study · 1997 · Circulation
5. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
   Jørgensen, Anders Berg, Frikke-Schmidt, Ruth, West, Anders Sode, Grande, Peer, Nordestgaard, Børge G., Tybjærg-Hansen, Anne · 2013 · European Heart Journal
6. Cognitive function in a randomized trial of evolocumab
   Giugliano, Robert P., Mach, François, Zavitz, Kenton, Kurtz, Christopher, Im, Kyungah, Kanevsky, Estella, Schneider, Jingjing, Wang, Huei, Keech, Anthony, Pedersen, Terje R. et al. · 2017 · New England Journal of Medicine
7. Statins for the prevention of dementia
   McGuinness, Bernadette, Craig, David, Bullock, Roger, Passmore, Peter · 2016 · Cochrane Database of Systematic Reviews
8. 9. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2018
   2017 · Diabetes Care
9. Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
   Moriarty, Patrick M., Thompson, Paul D., Cannon, Christopher P., Guyton, John R., Bergeron, Jean, Zieve, Franklin J., Bruckert, Eric, Jacobson, Terry A., Kopecky, Stephen L., Baccara-Dinet, Marie T. et al. · 2015 · Journal of Clinical Lipidology
10. ANGPTL3 deficiency and protection against coronary artery disease
    Stitziel, Nathan O., Khera, Amit V., Wang, Xiao, Bierhals, Andrew J., Vourakis, A. Christina, Sperry, Alexandra E., Natarajan, Pradeep, Klarin, Derek, Emdin, Connor A., Zekavat, Seyedeh M. et al. · 2017 · Journal of the American College of Cardiology
11. Association of Loss-of-Function Mutations in the <emph type="ital">ABCA1</emph> Gene With High-Density Lipoprotein Cholesterol Levels and Risk of Ischemic Heart Disease
    Frikke-Schmidt, Ruth · 2008 · JAMA
12. Prevalence, Impact, and Predictive Value of Detecting Subclinical Coronary and Carotid Atherosclerosis in Asymptomatic Adults
    Baber, Usman, Mehran, Roxana, Sartori, Samantha, Schoos, Mikkel Malby, Sillesen, Henrik, Muntendam, Pieter, Garcia, Mario J., Gregson, John, Pocock, Stuart, Falk, Erling et al. · 2015 · Journal of the American College of Cardiology
13. Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)
    Khera, Amit V., Everett, Brendan M., Caulfield, Michael P., Hantash, Feras M., Wohlgemuth, Jay, Ridker, Paul M, Mora, Samia · 2014 · Circulation
14. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
    Tsujita, Kenichi, Sugiyama, Seigo, Sumida, Hitoshi, Shimomura, Hideki, Yamashita, Takuro, Yamanaga, Kenshi, Komura, Naohiro, Sakamoto, Kenji, Oka, Hideki, Nakao, Koichi et al. · 2015 · Journal of the American College of Cardiology
15. 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
    Lloyd-Jones, Donald M., Morris, Pamela B., Ballantyne, Christie M., Birtcher, Kim K., Daly, David D., DePalma, Sondra M., Minissian, Margo B., Orringer, Carl E., Smith, Sidney C. · 2016 · Journal of the American College of Cardiology
16. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension
    Lan, Jiarong, Zhao, Yanyun, Dong, Feixia, Yan, Ziyou, Zheng, Wenjie, Fan, Jinping, Sun, Guoli · 2015 · Journal of Ethnopharmacology
17. A comprehensive meta-analysis on evidence of Mediterranean diet and cardiovascular disease: are individual components equal?
    Grosso, Giuseppe, Marventano, Stefano, Yang, Justin, Micek, Agnieszka, Pajak, Andrzej, Scalfi, Luca, Galvano, Fabio, Kales, Stefanos N. · 2017 · Critical Reviews in Food Science and Nutrition
18. Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women
    Liu, Simin, Manson, JoAnn E, Stampfer, Meir J, Holmes, Michelle D, Hu, Frank B, Hankinson, Susan E, Willett, Walter C · 2001 · The American Journal of Clinical Nutrition
19. Mechanism of action of niacin
    Kamanna, Vaijinath S., Kashyap, Moti L. · 2008 · The American Journal of Cardiology
20. Statins and All-Cause Mortality in High-Risk Primary Prevention: A Meta-analysis of 11 Randomized Controlled Trials Involving 65 229 Participants
    Ray, Kausik K. · 2010 · Archives of Internal Medicine
21. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events
    Mora, Samia, Rifai, Nader, Buring, Julie E., Ridker, Paul M · 2008 · Circulation
22. Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014
    Szummer, Karolina, Wallentin, Lars, Lindhagen, Lars, Alfredsson, Joakim, Erlinge, David, Held, Claes, James, Stefan, Kellerth, Thomas, Lindahl, Bertil, Ravn-Fischer, Annica et al. · 2017 · European Heart Journal
23. Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation
    Nauck, Matthias, Warnick, G Russell, Rifai, Nader · 2002 · Clinical Chemistry
24. Cholesterol Reduction Yields Clinical Benefit: Impact of Statin Trials
    Gould, A. Lawrence, Rossouw, Jacques E., Santanello, Nancy C., Heyse, Joseph F., Furberg, Curt D. · 1998 · Circulation
25. Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity
    Chalasani, Naga, Aljadhey, Hisham, Kesterson, Joe, Murray, Michael D., Hall, Stephen D. · 2004 · Gastroenterology
26. The effect of socioeconomic deprivation on the association between an extended measurement of unhealthy lifestyle factors and health outcomes: a prospective analysis of the UK Biobank cohort
    Foster, Hamish M E, Celis-Morales, Carlos A, Nicholl, Barbara I, Petermann-Rocha, Fanny, Pell, Jill P, Gill, Jason M R, O'Donnell, Catherine A, Mair, Frances S · 2018 · The Lancet Public Health
27. New insights into the pathophysiology of dyslipidemia in type 2 diabetes
    Taskinen, Marja-Riitta, Borén, Jan · 2015 · Atherosclerosis
28. Value and Limitations of Existing Scores for the Assessment of Cardiovascular Risk
    Cooney, Marie Therese, Dudina, Alexandra L., Graham, Ian M. · 2009 · Journal of the American College of Cardiology
29. Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study
    Mahshid Dehghan, Andrew Mente, Sumathy Rangarajan, Patrick Sheridan, Viswanathan Mohan, Romaina Iqbal, Rajeev Gupta, Scott Alexander Lear, Edelweiss Wentzel‐Viljoen, Álvaro Avezum et al. · 2018 · The Lancet
30. Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications
    Martin, Seth S., Blaha, Michael J., Elshazly, Mohamed B., Brinton, Eliot A., Toth, Peter P., McEvoy, John W., Joshi, Parag H., Kulkarni, Krishnaji R., Mize, Patrick D., Kwiterovich, Peter O. et al. · 2013 · Journal of the American College of Cardiology
31. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
    Giugliano, Robert P., Cannon, Christopher P., Blazing, Michael A., Nicolau, José C., Corbalán, Ramón, Špinar, Jindřich, Park, Jeong-Gun, White, Jennifer A., Bohula, Erin A., Braunwald, Eugene · 2018 · Circulation
32. Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
    Mills, Edward J., Rachlis, Beth, Wu, Ping, Devereaux, Philip J., Arora, Paul, Perri, Dan · 2008 · Journal of the American College of Cardiology
33. Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study
    Ballantyne, Christie M., Banach, Maciej, Mancini, G.B. John, Lepor, Norman E., Hanselman, Jeffrey C., Zhao, Xin, Leiter, Lawrence A. · 2018 · Atherosclerosis
34. Inactivating Mutations in <i>NPC1L1</i> and Protection from Coronary Heart Disease
    The Myocardial Infarction Genetics Consortium Investigators · 2014 · New England Journal of Medicine
35. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
    Asmaa S Abdelhamid, Tracey J. Brown, Julii Suzanne Brainard, Priti Biswas, Gabrielle Thorpe, Helen J. Moore, Katherine HO Deane, Fai K AlAbdulghafoor, Carolyn Dawn Summerbell, Helen V Worthington et al. · 2018 · Cochrane Database of Systematic Reviews
36. Safety considerations with fibrate therapy
    Davidson, Michael H., Armani, Annemarie, McKenney, James M., Jacobson, Terry A. · 2007 · The American Journal of Cardiology
37. Effect of Naturally Random Allocation to Lower Low-Density Lipoprotein Cholesterol on the Risk of Coronary Heart Disease Mediated by Polymorphisms in NPC1L1, HMGCR, or Both
    Ference, Brian A., Majeed, Faisal, Penumetcha, Raju, Flack, John M., Brook, Robert D. · 2015 · Journal of the American College of Cardiology
38. Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
    Gaudet, D, Méthot, J, Déry, S, Brisson, D, Essiembre, C, Tremblay, G, Tremblay, K, de Wal, J, Twisk, J, van den Bulk, N et al. · 2013 · Gene Therapy
39. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus
    Targher, Giovanni, Lonardo, Amedeo, Byrne, Christopher D. · 2018 · Nature Reviews Endocrinology
40. Effect of Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors on the Progression of Calcific Aortic Stenosis
    Gian M. Novaro, Irving Tiong, Gregory L. Pearce, Michael S. Lauer, Dennis L. Sprecher, Brian P. Griffin · 2001 · Circulation
41. Statin use and non-alcoholic steatohepatitis in at risk individuals
    Dongiovanni, Paola, Petta, Salvatore, Mannisto, Ville, Mancina, Rosellina Margherita, Pipitone, Rosaria, Karja, Vesa, Maggioni, Marco, Kakela, Pirjo, Wiklund, Olov, Mozzi, Enrico et al. · 2015 · Journal of Hepatology
42. The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease
    Kjekshus, John, Pedersen, Terje R., Olsson, Anders G., Færgeman, Ole, Pyörälä, Kalevi · 1997 · Journal of Cardiac Failure
43. Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures
    Miller, W Greg, Myers, Gary L, Sakurabayashi, Ikunosuke, Bachmann, Lorin M, Caudill, Samuel P, Dziekonski, Andrzej, Edwards, Selvin, Kimberly, Mary M, Korzun, William J, Leary, Elizabeth T et al. · 2010 · Clinical Chemistry
44. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease
    Sabatine, Marc S., Morrow, David A., Jablonski, Kathleen A., Rice, Madeline Murguia, Warnica, J. Wayne, Domanski, Michael J., Hsia, Judith, Gersh, Bernard J., Rifai, Nader, Ridker, Paul M et al. · 2007 · Circulation
45. 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
    Donald M. Lloyd‐Jones, Pamela Bowe Morris, Christie Mitchell Ballantyne, Kim K. Birtcher, David D. Daly, Sondra M. DePalma, Margo Minissian, Carl E. Orringer, Sidney C. Smith · 2017 · Journal of the American College of Cardiology
46. Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)
    de Ferranti, Sarah D., Rodday, Angie Mae, Mendelson, Michael M., Wong, John B., Leslie, Laurel K., Sheldrick, R. Christopher · 2016 · Circulation
47. PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
    Schmidt, Amand F, Swerdlow, Daniel I, Holmes, Michael V, Patel, Riyaz S, Fairhurst-Hunter, Zammy, Lyall, Donald M, Hartwig, Fernando Pires, Horta, Bernardo Lessa, Hyppönen, Elina, Power, Christine et al. · 2017 · The Lancet Diabetes &amp; Endocrinology
48. Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans
    Graham, Mark J., Lee, Richard G., Bell, Thomas A., Fu, Wuxia, Mullick, Adam E., Alexander, Veronica J., Singleton, Walter, Viney, Nick, Geary, Richard, Su, John et al. · 2013 · Circulation Research
49. Fluvastatin and Perioperative Events in Patients Undergoing Vascular Surgery
    Schouten, Olaf, Boersma, Eric, Hoeks, Sanne E., Benner, Robbert, van Urk, Hero, van Sambeek, Marc R.H.M., Verhagen, Hence J.M., Khan, Nisar A., Dunkelgrun, Martin, Bax, Jeroen J. et al. · 2009 · New England Journal of Medicine
50. National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey
    Salami, Joseph A., Warraich, Haider, Valero-Elizondo, Javier, Spatz, Erica S., Desai, Nihar R., Rana, Jamal S., Virani, Salim S., Blankstein, Ron, Khera, Amit, Blaha, Michael J. et al. · 2017 · JAMA Cardiology
51. Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
    Mach, François, Ray, Kausik K, Wiklund, Olov, Corsini, Alberto, Catapano, Alberico L, Bruckert, Eric, De Backer, Guy, Hegele, Robert A, Hovingh, G Kees, Jacobson, Terry A et al. · 2018 · European Heart Journal
52. Lipid-reduction variability and antidrug-antibody formation with bococizumab
    Ridker, Paul M, Tardif, Jean-Claude, Amarenco, Pierre, Duggan, William, Glynn, Robert J., Jukema, J. Wouter, Kastelein, John J.P., Kim, Albert M., Koenig, Wolfgang, Nissen, Steven et al. · 2017 · New England Journal of Medicine
53. Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
    Robinson, Jennifer G., Wang, Songfeng, Smith, Brian J., Jacobson, Terry A. · 2009 · Journal of the American College of Cardiology
54. Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification: A Cohort Study
    Kavousi, Maryam, Elias-Smale, Suzette, Rutten, Joost H.W., Leening, Maarten J.G., Vliegenthart, Rozemarijn, Verwoert, Germaine C., Krestin, Gabriel P., Oudkerk, Matthijs, de Maat, Moniek P.M., Leebeek, Frank W.G. et al. · 2012 · Annals of Internal Medicine
55. Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)
    Frederick Johan Raal, Robert Patrick Giugliano, Marc Steven Sabatine, Michael J. Koren, Gisle Langslet, Harold Edward Bays, Dirk Jacobus Blom, Mats Eriksson, Ricardo E. Dent, Scott M. Wasserman et al. · 2014 · Journal of the American College of Cardiology
56. Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)
    Bays, Harold E., Ballantyne, Christie M., Kastelein, John J., Isaacsohn, Jonathan L., Braeckman, Rene A., Soni, Paresh N. · 2011 · The American Journal of Cardiology
57. Early and Late Benefits of High-Dose Atorvastatin in Patients With Acute Coronary Syndromes
    Ray, Kausik K., Cannon, Christopher P., McCabe, Carolyn H., Cairns, Richard, Tonkin, Andrew M., Sacks, Frank M., Jackson, Graham, Braunwald, Eugene · 2005 · Journal of the American College of Cardiology
58. Chylomicronaemia–current diagnosis and future therapies
    Brahm, Amanda J., Hegele, Robert A. · 2015 · Nature Reviews Endocrinology
59. Dietary cholesterol and cardiovascular disease: a systematic review and meta-analysis
    Berger, Samantha, Raman, Gowri, Vishwanathan, Rohini, Jacques, Paul F, Johnson, Elizabeth J · 2015 · The American Journal of Clinical Nutrition
60. Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
    Cholesterol Treatment Trialists' (CTT) Collaboration · 2012 · PLoS ONE
61. Effect of Diabetes on Progression of Coronary Atherosclerosis and Arterial Remodeling
    Nicholls, Stephen J., Tuzcu, E. Murat, Kalidindi, Srinivasa, Wolski, Kathy, Moon, Keon-W., Sipahi, Ilke, Schoenhagen, Paul, Nissen, Steven E. · 2008 · Journal of the American College of Cardiology
62. Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis
    Leo E. Akioyamen, Jacques J. Genest, Shubham Shan, Rachel L Reel, Jordan M. Albaum, Anna Chu, Jack V. Tu · 2017 · BMJ Open
63. Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase
    Gupta, Ajay, Thompson, David, Whitehouse, Andrew, Collier, Tim, Dahlof, Bjorn, Poulter, Neil, Collins, Rory, Sever, Peter · 2017 · The Lancet
64. Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
    Ballantyne, Christie M., Bays, Harold E., Kastelein, John J., Stein, Evan, Isaacsohn, Jonathan L., Braeckman, Rene A., Soni, Paresh N. · 2012 · The American Journal of Cardiology
65. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT
    Bohula, Erin A., Giugliano, Robert P., Cannon, Christopher P., Zhou, Jing, Murphy, Sabina A., White, Jennifer A., Tershakovec, Andrew M., Blazing, Michael A., Braunwald, Eugene · 2015 · Circulation
66. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials
    Mills, E. J., WU, P., Chong, G., Ghement, I., Singh, S., Akl, E. A., Eyawo, O., Guyatt, G., Berwanger, O., Briel, M. · 2011 · QJM
67. Lipoprotein (a) measurements for clinical application
    Marcovina, Santica M., Albers, John J. · 2016 · Journal of Lipid Research
68. Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
    2016 · The Lancet Diabetes &amp; Endocrinology
69. Diabetes and its drivers: the largest epidemic in human history?
    Zimmet, Paul Z. · 2017 · Clinical Diabetes and Endocrinology
70. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
    Suetonia C. Palmer, Sankar Dass Navaneethan, Jonathan C. Craig, David Wayne Johnson, Vlado Perkovic, Jörgen Hegbrant, Giovanni FM Strippoli · 2014 · Cochrane Database of Systematic Reviews
71. Statins for the primary prevention of cardiovascular disease
    Shah B J Ebrahim, F. C. Taylor, P Brindle · 2014 · BMJ
72. Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial
    Rajamani, Kushwin, Colman, Peter G, Li, Li Ping, Best, James D, Voysey, Merryn, D'Emden, Michael C, Laakso, Markku, Baker, John R, Keech, Anthony C · 2009 · The Lancet
73. Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia
    Samia Mora, Robert J. Glynn, Judith A. Hsia, Jean G. MacFadyen, Jacques J. Genest, Paul M. Ridker · 2010 · Circulation
74. ANGPTL3 inhibition in homozygous familial hypercholesterolemia
    Gaudet, Daniel, Gipe, Daniel A., Pordy, Robert, Ahmad, Zahid, Cuchel, Marina, Shah, Prediman K., Chyu, Kuang-Yuh, Sasiela, William J., Chan, Kuo-Chen, Brisson, Diane et al. · 2017 · New England Journal of Medicine
75. Perioperative Rosuvastatin in Cardiac Surgery
    Zheng, Zhe, Jayaram, Raja, Jiang, Lixin, Emberson, Jonathan, Zhao, Yan, Li, Qi, Du, Juan, Guarguagli, Silvia, Hill, Michael, Chen, Zhengming et al. · 2016 · New England Journal of Medicine
76. Cost Effectiveness of Community-Based Physical Activity Interventions
    Larissa Roux, Michael Pratt, Tammy O. Tengs, Michelle M. Yore, Teri L. Yanagawa, Jill Van Den Bos, Candace Rutt, Ross C. Brownson, Kenneth E. Powell, Gregory W. Heath et al. · 2008 · American Journal of Preventive Medicine
77. Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing
    Einar Stefan Bjornsson, Elin I. Jacobsen, Evangelos Kalaitzakis · 2011 · Journal of Hepatology
78. Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
    SHARP Collaborative Group · 2010 · American Heart Journal
79. Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
    Pradhan, Aruna D., Paynter, Nina P., Everett, Brendan M., Glynn, Robert J., Amarenco, Pierre, Elam, Marshall, Ginsberg, Henry, Hiatt, William R., Ishibashi, Shun, Koenig, Wolfgang et al. · 2018 · American Heart Journal
80. Systematic review and meta‐analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors
    Santos, F. L., Esteves, S. S., da Costa Pereira, A., Yancy Jr, W. S., Nunes, J. P. L. · 2012 · Obesity Reviews
81. Dietary fat and cardiometabolic health: evidence, controversies, and consensus for guidance
    Nita G. Forouhi, Ronald M. Krauss, Gary Taubes, Walter Churchill Willett · 2018 · BMJ
82. Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort
    Henna Cederberg, Alena Stančáková, Nagendra Yaluri, Shalem Raju Modi, Johanna Kuusisto, Markku Laakso · 2015 · Diabetologia
83. Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention
    Di Sciascio, Germano, Patti, Giuseppe, Pasceri, Vincenzo, Gaspardone, Achille, Colonna, Giuseppe, Montinaro, Antonio · 2009 · Journal of the American College of Cardiology
84. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy
    Koenig, Wolfgang · 2013 · International Journal of Cardiology
85. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction
    Lu, Zongliang, Kou, Wenrong, Du, Baomin, Wu, Yangfeng, Zhao, Shuiping, Brusco, Osvaldo A., Morgan, John M., Capuzzi, David M. · 2008 · The American Journal of Cardiology
86. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
    Ray, Kausik K, Colhoun, Helen M, Szarek, Michael, Baccara-Dinet, Marie, Bhatt, Deepak L, Bittner, Vera A, Budaj, Andrzej J, Diaz, Rafael, Goodman, Shaun G, Hanotin, Corinne et al. · 2019 · The Lancet Diabetes &amp; Endocrinology
87. Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial
    Theodore M. Brasky, Amy K. Darke, Xiaoling Song, Catherine M. Tangen, Phyllis J. Goodman, Ian Murchie Thompson, Frank Louis Meyskens, Gary E. Goodman, Lori M. Minasian, Howard L. Parnes et al. · 2013 · JNCI Journal of the National Cancer Institute
88. Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement
    D. Kolovou, Genovefa, P. Mikhailidis, Dimitri, Kovar, Jan, Lairon, Dennis, G. Nordestgaard, Borge, Chye Ooi, Teik, Perez-Martinez, Pablo, Bilianou, Helen, Anagnostopoulou, Katherine, Panotopoulos, George · 2011 · Current Vascular Pharmacology
89. Association of genetic variants related to CETP inhibitors and statins with lipoprotein levels and cardiovascular risk
    Ference, Brian A., Kastelein, John J. P., Ginsberg, Henry N., Chapman, M. John, Nicholls, Stephen J., Ray, Kausik K., Packard, Chris J., Laufs, Ulrich, Brook, Robert D., Oliver-Williams, Clare et al. · 2017 · JAMA
90. The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review
    Loveman, E, Frampton, GK, Shepherd, J, Picot, J, Cooper, K, Bryant, J, Welch, K, Clegg, A · 2011 · Health Technology Assessment
91. Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients
    Morrisett, Joel D., Abdel-Fattah, Ghada, Hoogeveen, Ron, Mitchell, Eddie, Ballantyne, Christie M., Pownall, Henry J., Opekun, Antone R., Jaffe, Jonathon S., Oppermann, Suzanne, Kahan, Barry D. · 2002 · Journal of Lipid Research
92. Ezetimibe therapy: mechanism of action and clinical update
    Peter Paul Toth, Binh An P. Phan, Thomas D. Dayspring · 2012 · Vascular Health and Risk Management
93. Statin Therapy and the Risk of Intracerebral Hemorrhage: A Meta-Analysis of 31 Randomized Controlled Trials
    McKinney, James S., Kostis, William J. · 2012 · Stroke
94. Comparative Tolerability and Harms of Individual Statins: A Study-Level Network Meta-Analysis of 246 955 Participants From 135 Randomized, Controlled Trials
    Naci, Huseyin, Brugts, Jasper, Ades, Tony · 2013 · Circulation: Cardiovascular Quality and Outcomes
95. Report of the national heart, lung, and blood institute workshop on lipoprotein(a) and cardiovascular disease: recent advances and future directions
    Marcovina, Santica M, Koschinsky, Marlys L, Albers, John J, Skarlatos, Sonia · 2003 · Clinical Chemistry
96. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys
    Hajifathalian, Kaveh, Ueda, Peter, Lu, Yuan, Woodward, Mark, Ahmadvand, Alireza, Aguilar-Salinas, Carlos A, Azizi, Fereidoun, Cifkova, Renata, Di Cesare, Mariachiara, Eriksen, Louise et al. · 2015 · The Lancet Diabetes &amp; Endocrinology
97. Contraceptive hormone use and cardiovascular disease
    Shufelt, Chrisandra L., Bairey Merz, C. Noel · 2009 · Journal of the American College of Cardiology
98. Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a)
    Willeit, Peter, Kiechl, Stefan, Kronenberg, Florian, Witztum, Joseph L., Santer, Peter, Mayr, Manuel, Xu, Qingbo, Mayr, Agnes, Willeit, Johann, Tsimikas, Sotirios · 2014 · Journal of the American College of Cardiology
99. Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial
    Chasman, Daniel I., Giulianini, Franco, MacFadyen, Jean, Barratt, Bryan J., Nyberg, Fredrik, Ridker, Paul M · 2012 · Circulation: Cardiovascular Genetics
100. Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis
     Wei, Melissa Y., Jacobson, Terry A. · 2011 · Current Atherosclerosis Reports
101. Extreme lipoprotein(a) levels and improved cardiovascular risk prediction
     Kamstrup, Pia R., Tybjærg-Hansen, Anne, Nordestgaard, Børge G. · 2013 · Journal of the American College of Cardiology
102. Plasma Phospholipid Long-Chain ω-3 Fatty Acids and Total and Cause-Specific Mortality in Older Adults: A Cohort Study
     Mozaffarian, Dariush, Lemaitre, Rozenn N., King, Irena B., Song, Xiaoling, Huang, Hongyan, Sacks, Frank M., Rimm, Eric B., Wang, Molin, Siscovick, David S. · 2013 · Annals of Internal Medicine
103. ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
     Gordts, Philip L.S.M., Nock, Ryan, Son, Ni-Huiping, Ramms, Bastian, Lew, Irene, Gonzales, Jon C., Thacker, Bryan E., Basu, Debapriya, Lee, Richard G., Mullick, Adam E. et al. · 2016 · Journal of Clinical Investigation
104. Severe hypertriglyceridemia and pancreatitis: presentation and management
     Ewald, Nils, Hardt, Philip D, Kloer, Hans-Ulrich · 2009 · Current Opinion in Lipidology
105. Cholesterol Reduction Yields Clinical Benefit: A New Look at Old Data
     Gould, A. Lawrence, Rossouw, Jacques E., Santanello, Nancy C., Heyse, Joseph F., Furberg, Curt D. · 1995 · Circulation
106. Whole grain and body weight changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies
     Korrie Pol, Robin Christensen, Else Marie Bartels, Anne Raben, Inge Tetens, Mette Kristensen · 2013 · American Journal of Clinical Nutrition
107. A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults
     Stanhope, Kimber L, Medici, Valentina, Bremer, Andrew A, Lee, Vivien, Lam, Hazel D, Nunez, Marinelle V, Chen, Guoxia X, Keim, Nancy L, Havel, Peter J · 2015 · The American Journal of Clinical Nutrition
108. Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
     Paul M. Ridker · 2009 · Journal of Thrombosis and Haemostasis
109. Statins for children with familial hypercholesterolemia
     Alpo F. Vuorio, Jaana Kuoppala, Petri T. Kovanen, Steve Eric Humphries, Serena Tonstad, Albert Wiegman, Euridiki Drogari, Uma Ramaswami · 2017 · Cochrane Database of Systematic Reviews
110. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002
     Björck, Lena, Rosengren, Annika, Bennett, Kathleen, Lappas, George, Capewell, Simon · 2009 · European Heart Journal
111. Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review
     Jacobson, Terry A., Glickstein, Sara B., Rowe, Jonathan D., Soni, Paresh N. · 2012 · Journal of Clinical Lipidology
112. Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials
     Morrone, Doralisa, Weintraub, William S., Toth, Peter P., Hanson, Mary E., Lowe, Robert S., Lin, Jianxin, Shah, Arvind K., Tershakovec, Andrew M. · 2012 · Atherosclerosis
113. Impact of progressive resistance training on lipids and lipoproteins in adults: A meta-analysis of randomized controlled trials
     Kelley, George A., Kelley, Kristi S. · 2009 · Preventive Medicine
114. Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
     Langlois, Michel R, Chapman, M John, Cobbaert, Christa, Mora, Samia, Remaley, Alan T, Ros, Emilio, Watts, Gerald F, Borén, Jan, Baum, Hannsjörg, Bruckert, Eric et al. · 2018 · Clinical Chemistry
115. Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database
     Barter, Philip J., Brandrup-Wognsen, Gunnar, Palmer, Mike K., Nicholls, Stephen J. · 2010 · Journal of Lipid Research
116. The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis
     Lipinski, Michael J., Benedetto, Umberto, Escarcega, Ricardo O., Biondi-Zoccai, Giuseppe, Lhermusier, Thibault, Baker, Nevin C., Torguson, Rebecca, Brewer, H. Bryan, Waksman, Ron · 2016 · European Heart Journal
117. Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER
     Sabatine, Marc S., De Ferrari, Gaetano M., Giugliano, Robert P., Huber, Kurt, Lewis, Basil S., Ferreira, Jorge, Kuder, Julia F., Murphy, Sabina A., Wiviott, Stephen D., Kurtz, Christopher E. et al. · 2018 · Circulation
118. Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies
     THOMPSON, A., DANESH, J. · 2006 · Journal of Internal Medicine
119. Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials
     Konstantinos C. Koskinas, George C.M. Siontis, Raffaele Piccolo, Dimitris Mavridis, Lorenz Räber, François Mach, Stephan Windecker · 2017 · European Heart Journal
120. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial
     Tardif, J.-C., Ballantyne, C. M., Barter, P., Dasseux, J.-L., Fayad, Z. A., Guertin, M.-C., Kastelein, J. J. P., Keyserling, C., Klepp, H., Koenig, W. et al. · 2014 · European Heart Journal
121. Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease
     Ankur Pandya, Stephen Sy, Sylvia Cho, Milton C. Weinstein, Thomas Andrew Gaziano · 2015 · JAMA
122. A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency
     Barbara K. Burton, Manisha Balwani, François Feillet et al. · 2015 · New England Journal of Medicine
123. Statins Reduce Interleukin-6–Induced C-Reactive Protein in Human Hepatocytes: New Evidence for Direct Antiinflammatory Effects of Statins
     Arnaud, Claire, Burger, Fabienne, Steffens, Sabine, Veillard, Niels R., Nguyen, Tuan Huy, Trono, Didier, Mach, François · 2005 · Arteriosclerosis, Thrombosis, and Vascular Biology
124. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): expert panel recommendations and proposal of an "FCS score
     Moulin, Philippe, Dufour, Robert, Averna, Maurizio, Arca, Marcello, Cefalù, Angelo B., Noto, Davide, D'Erasmo, Laura, Di Costanzo, Alessia, Marçais, Christophe, Alvarez-Sala Walther, Luis Antonio et al. · 2018 · Atherosclerosis
125. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis
     Maeda, Kenji, Noguchi, Yoshinori, Fukui, Tsuguya · 2003 · Preventive Medicine
126. Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study
     Brownrigg, Jack R W, Hughes, Cian O, Burleigh, David, Karthikesalingam, Alan, Patterson, Benjamin O, Holt, Peter J, Thompson, Matthew M, de Lusignan, Simon, Ray, Kausik K, Hinchliffe, Robert J · 2016 · The Lancet Diabetes &amp; Endocrinology
127. Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: a meta-analysis
     Lee, Meng, Saver, Jeffrey L., Towfighi, Amytis, Chow, Jessica, Ovbiagele, Bruce · 2011 · Atherosclerosis
128. Novel Approaches for Preventing or Limiting Events (Naples) II Trial
     Briguori, Carlo, Visconti, Gabriella, Focaccio, Amelia, Golia, Bruno, Chieffo, Alaide, Castelli, Alfredo, Mussardo, Marco, Montorfano, Matteo, Ricciardelli, Bruno, Colombo, Antonio · 2009 · Journal of the American College of Cardiology
129. Association of Low-Density Lipoprotein Cholesterol–Related Genetic Variants With Aortic Valve Calcium and Incident Aortic Stenosis
     Smith, J. Gustav, Luk, Kevin, Schulz, Christina-Alexandra, Engert, James C., Do, Ron, Hindy, George, Rukh, Gull, Dufresne, Line, Almgren, Peter, Owens, David S. et al. · 2014 · JAMA
130. Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy: 20-Year Follow-Up of West of Scotland Coronary Prevention Study
     Ford, Ian, Murray, Heather, McCowan, Colin, Packard, Chris J. · 2016 · Circulation
131. Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis
     Zomer, E., Gurusamy, K., Leach, R., Trimmer, C., Lobstein, T., Morris, S., James, W.P.T., Finer, N. · 2016 · Obesity Reviews
132. Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial
     Kastelein, John J.P., Maki, Kevin C., Susekov, Andrey, Ezhov, Marat, Nordestgaard, Borge G., Machielse, Ben N., Kling, Douglas, Davidson, Michael H. · 2014 · Journal of Clinical Lipidology
133. Whole-grain and blood lipid changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies
     Hollænder, Pernille LB, Ross, Alastair B, Kristensen, Mette · 2015 · The American Journal of Clinical Nutrition
134. An assessment by the Statin Liver Safety Task Force: 2014 update
     Harold Edward Bays, David E. Cohen, Naga Chalasani, Stephen A. Harrison · 2014 · Journal of clinical lipidology
135. Statins for the treatment of dementia
     Bernadette McGuinness, David Craig, Roger Alan Bullock, Reem Saleem Malouf, Peter Passmore · 2014 · Cochrane Database of Systematic Reviews
136. Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol &lt;50 mg/dl With Rosuvastatin
     Hsia, Judith, MacFadyen, Jean G., Monyak, John, Ridker, Paul M. · 2011 · Journal of the American College of Cardiology
137. Is carotid intima media thickness useful for individual prediction of cardiovascular risk? Ten-year results from the Carotid Atherosclerosis Progression Study (CAPS)
     Lorenz, M. W., Schaefer, C., Steinmetz, H., Sitzer, M. · 2010 · European Heart Journal
138. Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta‐analysis of randomized controlled trials
     Pandor, A., Ara, R. M., Tumur, I., Wilkinson, A. J., Paisley, S., Duenas, A., Durrington, P. N., Chilcott, J. · 2009 · Journal of Internal Medicine
139. Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk
     Chapman, M. John, Redfern, Jan S., McGovern, Mark E., Giral, Philippe · 2010 · Pharmacology &amp; Therapeutics
140. Lipid management in chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2013 clinical practice guideline
     Tonelli, Marcello, Wanner, Christoph, for the Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members* · 2014 · Annals of Internal Medicine
141. Resistance and intolerance to statins
     Reiner, Ž. · 2014 · Nutrition, Metabolism and Cardiovascular Diseases
142. High-Dose Atorvastatin Reduces Total Plasma Levels of Oxidized Phospholipids and Immune Complexes Present on Apolipoprotein B-100 in Patients With Acute Coronary Syndromes in the MIRACL Trial
     Tsimikas, Sotirios, Witztum, Joseph L., Miller, Elizabeth R., Sasiela, William J., Szarek, Michael, Olsson, Anders G., Schwartz, Gregory G. · 2004 · Circulation
143. Cardiovascular Risk-Estimation Systems in Primary Prevention: Do They Differ? Do They Make a Difference? Can We See the Future?
     Cooney, Marie Therese, Dudina, Alexandra, D'Agostino, Ralph, Graham, Ian M. · 2010 · Circulation
144. Association of Common <i>CRP</i> Gene Variants with CRP Levels and Cardiovascular Events
     Miller, D. T., Zee, R. Y. L., Suk Danik, J., Kozlowski, P., Chasman, D. I., Lazarus, R., Cook, N. R., Ridker, P. M., Kwiatkowski, D. J. · 2005 · Annals of Human Genetics
145. Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial
     Ahern, Amy L, Wheeler, Graham M, Aveyard, Paul, Boyland, Emma J, Halford, Jason C G, Mander, Adrian P, Woolston, Jennifer, Thomson, Ann M, Tsiountsioura, Melina, Cole, Darren et al. · 2017 · The Lancet
146. Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
     Lin, Jennifer S., Evans, Corinne V., Johnson, Eric, Redmond, Nadia, Coppola, Erin L., Smith, Ning · 2018 · JAMA
147. What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice
     Finegold, Judith A, Manisty, Charlotte H, Goldacre, Ben, Barron, Anthony J, Francis, Darrel P · 2014 · European Journal of Preventive Cardiology
148. Effect of Alirocumab, a Monoclonal Proprotein Convertase Subtilisin/Kexin 9 Antibody, on Lipoprotein(a) Concentrations (a Pooled Analysis of 150 mg Every Two Weeks Dosing from Phase 2 Trials)
     Daniel Gaudet, Dean J. Kereiakes, James M. McKenney, Eli M. Roth, Corinne Hanotin, Daniel A. Gipe, Yunling E. Du, Anne-Catherine Ferrand, Henry N. Ginsberg, Evan A. Stein · 2014 · The American Journal of Cardiology
149. Bezafibrate in men with lower extremity arterial disease: randomised controlled trial
     Meade, Tom, Zuhrie, Riaz, Cook, Claire, Cooper, Jackie · 2002 · BMJ
150. Lipid-lowering for peripheral arterial disease of the lower limb
     Phyu Phyu Aung, Heather Maxwell, Ruth Gillian Jepson, Jackie F. Price, Gillian C. Leng · 2007 · Cochrane Database of Systematic Reviews
151. Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome
     Murphy, Sabina A., Cannon, Christopher P., Blazing, Michael A., Giugliano, Robert P., White, Jennifer A., Lokhnygina, Yuliya, Reist, Craig, Im, KyungAh, Bohula, Erin A., Isaza, Daniel et al. · 2016 · Journal of the American College of Cardiology
152. Atherothrombotic risk stratification and ezetimibe for secondary prevention
     Bohula, Erin A., Morrow, David A., Giugliano, Robert P., Blazing, Michael A., He, Ping, Park, Jeong-Gun, Murphy, Sabina A., White, Jennifer A., Kesaniemi, Y. Antero, Pedersen, Terje R. et al. · 2017 · Journal of the American College of Cardiology
153. Carotid plaque thickness and carotid plaque burden predict future cardiovascular events in asymptomatic adult Americans
     Sillesen, Henrik, Sartori, Samantha, Sandholt, Benjamin, Baber, Usman, Mehran, Roxana, Fuster, Valentin · 2018 · European Heart Journal - Cardiovascular Imaging
154. PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease
     Amand Floriaan Schmidt, Lucy S Pearce, John T. Wilkins, John P. Overington, Aroon Dinesh Hingorani, Juan Pablo Casas · 2017 · Cochrane Database of Systematic Reviews
155. Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials
     Naci, Huseyin, Brugts, Jasper J, Fleurence, Rachael, Tsoi, Bernice, Toor, Harleen, Ades, AE · 2013 · European Journal of Preventive Cardiology
156. Association of fructose consumption and components of metabolic syndrome in human studies: a systematic review and meta-analysis
     Kelishadi, Roya, Mansourian, Marjan, Heidari-Beni, Motahar · 2014 · Nutrition
157. Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects
     Rivellese, Angela A, Maffettone, Ada, Vessby, Bengt, Uusitupa, Matti, Hermansen, Kjeld, Berglund, Lars, Louheranta, Anne, Meyer, Barbara J, Riccardi, Gabriele · 2003 · Atherosclerosis
158. Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab
     Robinson, Jennifer G., Rosenson, Robert S., Farnier, Michel, Chaudhari, Umesh, Sasiela, William J., Merlet, Laurence, Miller, Kathryn, Kastelein, John J.P. · 2017 · Journal of the American College of Cardiology
159. Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study
     Pelham M Barton, Lazaros Andronis, Andrew H. Briggs, K. McPherson, Simon Capewell · 2011 · BMJ
160. Type 1 diabetes, metabolic syndrome and cardiovascular risk
     Chillarón, Juan J., Flores Le-Roux, Juana A., Benaiges, David, Pedro-Botet, Juan · 2014 · Metabolism
161. A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: results of a meta-analysis of randomized, placebo-controlled trials
     Musa-Veloso, Kathy, Poon, Theresa H., Elliot, Julie Ann, Chung, Catherine · 2011 · Prostaglandins, Leukotrienes and Essential Fatty Acids
162. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions
     Kornelia Kotseva, Dirk De Bacquer, Guy De Backer, Lars Rydén, Catriona Sian Jennings, Viveca Gyberg, Ana Abreu, Carlos Aguíar, Almudena Castro Conde, Kairat Davletov et al. · 2016 · European Journal of Preventive Cardiology
163. Fibrates effect on cardiovascular risk is greater in patients with high triglyceride levels or atherogenic dyslipidemia profile: a systematic review and meta-analysis
     Bruckert, Eric, Labreuche, Julien, Deplanque, Dominique, Touboul, Pierre-Jean, Amarenco, Pierre · 2011 · Journal of Cardiovascular Pharmacology
164. Effects of Fibrates in Kidney Disease
     Jun, Min, Zhu, Bin, Tonelli, Marcello, Jardine, Meg J., Patel, Anushka, Neal, Bruce, Liyanage, Thaminda, Keech, Anthony, Cass, Alan, Perkovic, Vlado · 2012 · Journal of the American College of Cardiology
165. Clinical Benefit of Statin Pretreatment in Patients Undergoing Percutaneous Coronary Intervention
     Giuseppe Patti, Christopher Paul Cannon, Sabina A. Murphy, Simona Mega, Vincenzo Pasceri, Carlo Briguori, Antonio Colombo, Kyeong Ho Yun, Myung Ho Jeong, Jung‐Sun Kim et al. · 2011 · Circulation
166. Statins and Intracerebral Hemorrhage
     Daniel G. Hackam, Mark Woodward, Laura Kristin Newby, Deepak L. Bhatt, Mingyuan Shao, Eric Edward Smith, Allan Donner, Muhammad Mamdani, James Demetrios Douketis, Hisatomi Arima et al. · 2011 · Circulation
167. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial
     Vallejo-Vaz, Antonio J., Fayyad, Rana, Boekholdt, S. Matthijs, Hovingh, G. Kees, Kastelein, John J., Melamed, Shari, Barter, Philip, Waters, David D., Ray, Kausik K. · 2018 · Circulation
168. Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes
     Elam, Marshall B., Ginsberg, Henry N., Lovato, Laura C., Corson, Marshall, Largay, Joseph, Leiter, Lawrence A., Lopez, Carlos, O’Connor, Patrick J., Sweeney, Mary Ellen, Weiss, Daniel et al. · 2017 · JAMA Cardiology
169. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up
     Vallejo-Vaz, Antonio J., Robertson, Michele, Catapano, Alberico L., Watts, Gerald F., Kastelein, John J., Packard, Chris J., Ford, Ian, Ray, Kausik K. · 2017 · Circulation
170. Rationale and design of <scp>REDUCE‐IT</scp> : Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial
     Bhatt, Deepak L., Steg, Ph. Gabriel, Brinton, Eliot A., Jacobson, Terry A., Miller, Michael, Tardif, Jean‐Claude, Ketchum, Steven B., Doyle, Ralph T., Murphy, Sabina A., Soni, Paresh N. et al. · 2017 · Clinical Cardiology
171. Efficacy of High-Dose Atorvastatin Loading Before Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction
     Kim, Jung-Sun, Kim, Jaedeok, Choi, Donghoon, Lee, Chan Joo, Lee, Sang Hak, Ko, Young-Guk, Hong, Myeong-Ki, Kim, Byoung-Keuk, Oh, Seong Jin, Jeon, Dong Woon et al. · 2010 · JACC: Cardiovascular Interventions
172. Dairy fat and risk of cardiovascular disease in 3 cohorts of US adults
     Chen, Mu, Li, Yanping, Sun, Qi, Pan, An, Manson, JoAnn E, Rexrode, Kathryn M, Willett, Walter C, Rimm, Eric B, Hu, Frank B · 2016 · The American Journal of Clinical Nutrition
173. Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 Study
     Scirica, Benjamin M., Morrow, David A., Cannon, Christopher P., Ray, Kausik K., Sabatine, Marc S., Jarolim, Petr, Shui, Amy, McCabe, Carolyn H., Braunwald, Eugene · 2006 · Journal of the American College of Cardiology
174. Lipid-Modifying Therapies and Risk of Pancreatitis: A Meta-analysis
     Preiss, David, Tikkanen, Matti J., Welsh, Paul, Ford, Ian, Lovato, Laura C., Elam, Marshall B., LaRosa, John C., DeMicco, David A., Colhoun, Helen M., Goldenberg, Ilan et al. · 2012 · JAMA
175. Dietary fibre for the primary prevention of cardiovascular disease
     Louise Hartley, Michael D May, Emma Loveman, Jill L Colquitt, Karen Rees · 2016 · Cochrane Database of Systematic Reviews
176. Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy
     Waters, David D., Ho, Jennifer E., Boekholdt, S. Matthijs, DeMicco, David A., Kastelein, John J.P., Messig, Michael, Breazna, Andrei, Pedersen, Terje R. · 2013 · Journal of the American College of Cardiology
177. Relation of atherosclerotic changes in retinal arteries to the extent of coronary artery disease
     Tedeschi-Reiner, Eugenia, Strozzi, Maja, Skoric, Bosko, Reiner, Zeljko · 2005 · The American Journal of Cardiology
178. A systematic review of the effect of dietary saturated and polyunsaturated fat on heart disease
     Peter Marshall Clifton, Jennifer Beatrice Keogh · 2017 · Nutrition Metabolism and Cardiovascular Diseases
179. The risks of statin use in pregnancy: a systematic review
     Karalis, Dean G., Hill, Alethea N., Clifton, Shari, Wild, Robert A. · 2016 · Journal of Clinical Lipidology
180. Cardiovascular risk estimation in older persons: SCORE O.P
     Cooney, Marie Therese, Selmer, Randi, Lindman, Anja, Tverdal, Aage, Menotti, Alessandro, Thomsen, Troels, DeBacker, Guy, De Bacquer, Dirk, Tell, Grethe S, Njolstad, Inger et al. · 2016 · European Journal of Preventive Cardiology
181. Effect of High-Dose Atorvastatin on Hospitalizations for Heart Failure: Subgroup Analysis of the Treating to New Targets (TNT) Study
     Khush, Kiran K., Waters, David D., Bittner, Vera, Deedwania, Prakash C., Kastelein, John J.P., Lewis, Sandra J., Wenger, Nanette K. · 2007 · Circulation
182. Antisense-mediated lowering of plasma apolipoprotein C-III by volanesorsen improves dyslipidemia and insulin sensitivity in type 2 diabetes
     Digenio, Andres, Dunbar, Richard L., Alexander, Veronica J., Hompesch, Marcus, Morrow, Linda, Lee, Richard G., Graham, Mark J., Hughes, Steven G., Yu, Rosie, Singleton, Walter et al. · 2016 · Diabetes Care
183. Effects of oils and solid fats on blood lipids: a systematic review and network meta-analysis
     Lukas Schwingshackl, Berit Bogensberger, Aleksander Benčič, Sven Knüppel, Heiner Boeing, Georg E. HOFFMANN · 2018 · Journal of Lipid Research
184. Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: rationale and design of the STRENGTH trial
     Nicholls, Stephen J., Lincoff, A. Michael, Bash, Dianna, Ballantyne, Christie M., Barter, Philip J., Davidson, Michael H., Kastelein, John J. P., Koenig, Wolfgang, McGuire, Darren K., Mozaffarian, Dariush et al. · 2018 · Clinical Cardiology
185. Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial
     Araki, Eiichi, Yamashita, Shizuya, Arai, Hidenori, Yokote, Koutaro, Satoh, Jo, Inoguchi, Toyoshi, Nakamura, Jiro, Maegawa, Hiroshi, Yoshioka, Narihito, Tanizawa, Yukio et al. · 2018 · Diabetes Care
186. Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipients
     Kasiske, B.L., de Mattos, A., Flechner, S.M., Gallon, L., Meier-Kriesche, H.-U., Weir, M.R., Wilkinson, A. · 2008 · American Journal of Transplantation
187. Revisiting the links between glycaemia, diabetes and cardiovascular disease
     Sattar, N. · 2013 · Diabetologia
188. European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk
     Ulf Landmesser, M. John Chapman, Michel Farnier, Bariş Gencer, Stephan Gielen, G. Kees Hovingh, Thomas Felix Lüscher, David Sinning, Lale S Tokgözoğlu, Olov Wiklund et al. · 2016 · European Heart Journal
189. Comparative Safety of Atorvastatin 80 mg Versus 10 mg Derived from Analysis of 49 Completed Trials in 14,236 Patients
     Connie B. Newman, John Tsai, Michael J. Szarek, Don Luo, Eric Gibson · 2005 · The American Journal of Cardiology
190. Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration
     Ference, Brian A, Cannon, Christopher P, Landmesser, Ulf, Lüscher, Thomas F, Catapano, Alberico L, Ray, Kausik K · 2018 · European Heart Journal
191. The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials
     Preiss, David, Campbell, Ross T., Murray, Heather M., Ford, Ian, Packard, Chris J., Sattar, Naveed, Rahimi, Kazem, Colhoun, Helen M., Waters, David D., LaRosa, John C. et al. · 2015 · European Heart Journal
192. Weight Loss Interventions in Older Adults with Obesity: A Systematic Review of Randomized Controlled Trials Since 2005
     Batsis, John A., Gill, Lydia E., Masutani, Rebecca K., Adachi‐Mejia, Anna M., Blunt, Heather B., Bagley, Pamela J., Lopez‐Jimenez, Francisco, Bartels, Stephen J. · 2017 · Journal of the American Geriatrics Society
193. Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials
     Rahimi, K., Emberson, J., McGale, P., Majoni, W., Merhi, A., Asselbergs, F. W., Krane, V., Macfarlane, P. W., PWM is acting on behalf of the PROSPER Executive · 2011 · BMJ
194. Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase reduce receptor-mediated endocytosis in opossum kidney cells
     Sidaway, James E., Davidson, Robert G., McTaggart, Fergus, Orton, Terry C., Scott, Robert C., Smith, Graham J., Brunskill, Nigel J. · 2004 · Journal of the American Society of Nephrology
195. Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
     Moriarty, Patrick M., Jacobson, Terry A., Bruckert, Eric, Thompson, Paul D., Guyton, John R., Baccara-Dinet, Marie T., Gipe, Daniel · 2014 · Journal of Clinical Lipidology
196. Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease
     Gregg C. Fonarow, ANTHONY C. KEECH, Terje Rolf Pedersen, Robert Patrick Giugliano, Peter S. Sever, Peter Lindgren, Ben van Hout, Guillermo Villa, Yi Qian, Ransi M. Somaratne et al. · 2017 · JAMA Cardiology
197. Untitled work
     Veenkamp · 2002 · 10.1161/hq0202.104059
198. Hypertriglyceridemia in the genomic era: a new paradigm
     Lewis, Gary F., Xiao, Changting, Hegele, Robert A. · 2015 · Endocrine Reviews
199. The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop
     Carla Guerriero, John Cairns, Ian Roberts, Anthony Rodgers, Robyn Whittaker, Caroline Free · 2012 · The European Journal of Health Economics
200. Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology
     Perrone-Filardi, Pasquale, Achenbach, Stephan, Möhlenkamp, Stefan, Reiner, Zeljko, Sambuceti, Gianmario, Schuijf, Joanne D., Van der Wall, Ernst, Kaufmann, Philip A., Knuuti, Juhani, Schroeder, Stephen et al. · 2011 · European Heart Journal